Suicidal Risk in Adults in Panama: Validation of a Clinical Intervention Protocol

Starting soon · Not applicable

Conditions studied: Suicide Risk

In brief

This study aims to validate MBT as an effective and viable intervention for implementation in public health services, with the potential to directly impact suicide prevention policies in the region.

Key facts

Study ID

NCT07717320

Run by

Fundación Judío Panameña (JUPA)

People needed

300

Starts

2026-11-01

Expected to finish

2028-05-01

Last updated by the study team

2026-07-27

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age and consent
• Presence of suicidal ideation or active behavior in the last month, assessed using the C-SSRS (e.g., intentional ideation, plan, or preparatory behavior)
• Depressive or anxious symptoms (Score ≥ 10 on the PHQ-9, indicating at least moderate depressive symptoms, or Score ≥ 10 on the GAD-7, suggesting clinically significant anxiety.)
• Availability and commitment to participate in the full assessment using all the aforementioned scales.

You may not qualify if…

• Clinical Safety (exclude and refer immediately)
• Imminent suicide risk according to the C-SSRS (e.g., attempt within the last 7 days, current intentional plan, access to lethal means, and low ambivalence).
• PHQ-9 item 9 = 3 ("almost every day") with clinical corroboration of imminent risk.
• Current self-harm with lethality/high-harm moderator requiring acute restraint.
• Refusal to establish a safety plan or allow emergency contact.
• Acute Psychiatric Conditions/Contraindications of Assessment
• Active psychosis or unstabilized manic episode.
• Substance use disorder in intoxication or acute withdrawal (e.g., last 24-72 hours) that precludes valid assessment.
• Uncontrolled risk of severe other-directed violence.
• Medical or neurological conditions that preclude valid participation
• Severe cognitive impairment (e.g., dementia, recent moderate-to-severe traumatic brain injury) that prevents understanding/answering scales.
• Decompensated medical illness (e.g., desaturation, delirium, severe uncontrolled pain).
• Unstable neurological condition (e.g., uncontrolled seizures).
• Methodological interferences
• Recent changes in baseline psychotropic medications within the last 2 weeks.
• Concurrent intensive psychotherapy initiated within the last 4 weeks.
• Simultaneous participation in another trial that could contaminate results.
• Language other than that of the scales without available validation.
• Logistical impossibility for follow-up (no telephone/stable contact; imminent relocation plan).
• Legal aspects/consent
• Incapacity to consent (legal or clinical) and no available representative.
• Legal restrictions that prevent participation.

Where it is running

• Consultorio Inter Cambio — Panama City, Provincia de Panamá, Panama
• Panama City Health Ministry Clinics — Panama City, Provincia de Panamá, Panama

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.